pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
raps·Aug 19·1 min read
save

President Trump nominates White House aide Heidi Overton as FDA Commissioner

Aug 19, 2026·read at raps ↗RegulatoryNeutral

President Donald Trump announced on his Truth Social platform that Heidi Overton, a White House aide, will be nominated to lead the U.S. Food and Drug Administration.

Overton is set to replace Marty Makary, who departed the agency in May. The nomination will now move to the Senate for confirmation.

The appointment signals the administration’s continued involvement in FDA leadership, though the article does not detail policy implications.

source

This writeup was produced by pharmadog from original reporting by raps.

Original headline: “Trump taps Heidi Overton as next FDA Commissioner”

read at raps ↗
73 words · retrieved Aug 20
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1d agoSingle pivotal trials: Stakeholders seek definitions, clarification about evidentiary standardraps
  • 1d agoFDA call for new adcomm members signals renewed interest in outside advisorsraps
  • 2d agoConvergence: Regulators highlight efforts to streamline the European regulatory frameworkraps
  • 2d agoFDA draft guidance addresses considerations for robotically assisted surgical devicesraps
  • 2d agoRecon: FDA approves Egetis’ Emcitate for rare genetic disease; Novo buys rights to Chinese weight-loss pill in $2.6B dealraps